多发性硬化症

来自妙佑医疗国际员工
Aug. 29, 2026

研究

妙佑医疗国际的研究人员致力于改善多发性硬化症的诊断和治疗。具体工作包括寻找该疾病的原因以及制定髓鞘再生和轴索修复的策略。

请阅读更多关于妙佑医疗检测以及多发性硬化症和自身免疫性神经病学中心的研究内容。

著述

查看美国国家医学图书馆检索服务系统 PubMed 所收录的妙佑医疗国际的医生在多发性硬化症领域的著述目录。

  1. What is multiple sclerosis? National Multiple Sclerosis Society. https://www.nationalmssociety.org/What-is-MS. Accessed June 10, 2024.
  2. Clinical overview: Multiple sclerosis. Elsevier Point of Care. 2023. https://www.clinicalkey.com. Accessed June 19, 2024.
  3. Olek MJ, et al. Clinical presentation, course, and prognosis of multiple sclerosis in adults. https://www.uptodate.com/contents/search. Accessed June 19, 2024.
  4. Olek MJ, et al. Pathogenesis and epidemiology of multiple sclerosis. https://www.uptodate.com/contents/search. Accessed June 19, 2024.
  5. Olek MJ, et al. Evaluation and diagnosis of multiple sclerosis in adults. https://www.uptodate.com/contents/search. Accessed June 19, 2024.
  6. Olek MJ, et al. Treatment of acute exacerbations of multiple sclerosis in adults. https://www.uptodate.com/contents/search. Accessed June 19, 2024.
  7. Olek MJ, et al. Initial disease-modifying therapy for relapsing-remitting multiple sclerosis in adults. https://www.uptodate.com/contents/search. Accessed June 19, 2024.
  8. Olek MJ, et al. Clinical use of monoclonal antibody disease-modifying therapies for multiple sclerosis. https://www.uptodate.com/contents/search. Accessed June 19, 2024.
  9. Olek MJ, et al. Clinical use of oral disease-modifying therapies for multiple sclerosis. https://www.uptodate.com/contents/search. Accessed June 19, 2024.
  10. Olek MJ, et al. Symptom management of multiple sclerosis in adults. https://www.uptodate.com/contents/search. Accessed June 19, 2024.
  11. Olek MJ, et al. Overview of disease-modifying therapies for multiple sclerosis. https://www.uptodate.com/contents/search. Accessed June 19, 2024.
  12. Olek MJ, et al. Manifestations of multiple sclerosis in adults. https://www.uptodate.com/contents/search. Accessed June 19, 2024.
  13. Jankovic J, et al., eds. Multiple sclerosis and other inflammatory demyelinating diseases of the central nervous system. In: Bradley and Daroff's Neurology in Clinical Practice. 8th ed. Elsevier; 2022. https://www.clinicalkey.com. Accessed June 19, 2024.
  14. Pizzorno JE, et al., eds. Multiple sclerosis. In: Textbook of Natural Medicine. 5th ed. Elsevier; 2021. https://www.clinicalkey.com. Accessed June 19, 2024.
  15. Krämer J, et al. Bruton tyrosine kinase inhibitors for multiple sclerosis. Nature Reviews Neurology. 2023; doi:10.1038/s41582-023-00800-7.
  16. Pediatric MS. National Multiple Sclerosis Society. https://www.nationalmssociety.org/for-professionals/for-healthcare-professionals/managing-and-treating-ms/pediatric-ms. Accessed June 19, 2024.
  17. Multiple sclerosis. National Institute of Neurological Disorders and Stroke. https://www.ninds.nih.gov/health-information/disorders/multiple-sclerosis#. Accessed June 24, 2024.
  18. Saadeh RS, et al. CSF kappa free light chains: Cutoff validation for diagnosing multiple sclerosis. Mayo Clinic Proceedings. 2022; doi:10.1016/j.mayocp.2021.09.014.
  19. Nimmagadda R. Allscripts EPSi. Mayo Clinic. May 13, 2024.
  20. Deb C. CD8+ T cells cause disability and axon loss in a mouse model of multiple sclerosis. PLOS One. 2010; doi:101371/journal.pone.0012478.
  21. Fadul CE, et al. Safety and immune effects of blocking CD40 ligand in multiple sclerosis. Neurology Journals. 2021; doi:10.1212/NXI.0000000000001096.
  22. Nakamura K, et al. Ibudilast reduces slowly enlarging lesions in progressive multiple sclerosis. Multiple Sclerosis Journal. 2024; doi:10.1177/13524585231224702.
  23. Katz Sand I, et al. Mediterranean diet is linked to less objective disability in multiple sclerosis. Multiple Sclerosis Journal. 2023; doi:10.1177/13524585221127414.
  24. Kantarci OH, et al. Novel immunomodulatory approaches for the management of multiple sclerosis. Clinical Pharmacology & Therapeutics. 2014; doi:10.1038/clpt.2013.196.
  25. Winn HR, ed. Neuropsychological testing. In: Youmans and Winn Neurological Surgery. 8th ed. Elsevier; 2023. https://www.clinicalkey.com. Accessed Oct. 21, 2024.
  26. Hancock LM, et al. Neuropsychological manifestations of multiple sclerosis. Neurologic Clinics. 2024; doi:10.1016/j.ncl.2024.05.010.